| 000 | 01051 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250512013419.0 | ||
| 264 | 0 | _c19900123 | |
| 008 | 199001s 0 0 eng d | ||
| 022 | _a8756-0437 | ||
| 024 | 7 |
_a10.1002/ssu.2980050607 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPollock, R E | |
| 245 | 0 | 0 |
_aCancer-induced immunosuppression: implications for therapy? _h[electronic resource] |
| 260 |
_bSeminars in surgical oncology _c1989 |
||
| 300 |
_a414-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
| 650 | 0 | 4 |
_aImmune Tolerance _ximmunology |
| 650 | 0 | 4 |
_aInterleukin-2 _ximmunology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 |
_aNeoplasms, Experimental _ximmunology |
| 650 | 0 | 4 |
_aTransforming Growth Factors _ximmunology |
| 700 | 1 | _aRoth, J A | |
| 773 | 0 |
_tSeminars in surgical oncology _gvol. 5 _gno. 6 _gp. 414-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ssu.2980050607 _zAvailable from publisher's website |
| 999 |
_c2693913 _d2693913 |
||